Inception Return
(11/4/2022)
|
-11.56 %
|
|
YTD Return
|
-19.78 %
|
|
NAVPS
(10/16/2024)
|
$7.61
|
|
Change
|
$0.05 / 0.69 %
|
|
|
Growth of $10,000
(As of September 30, 2024)
|
|
MER
|
0.85 %
|
|
Assets ($mil)
|
$6.56
|
|
Rank (1Yr)
|
175/185
|
|
Std Dev (3Yr)
|
-
|
|
Volatility Ranking (3Yr)
|
-
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund’s objective is to provide long-term capital growth by investing primarily in equity securities of companies involved in disruptive genomic innovation from around the world.
|
Fund Manager
BMO Investments Inc.
Portfolio Manager
Nicholas Grous, Ark Investment Management LLC
Dan White, Ark Investment Management LLC
Catherine D. Wood, Ark Investment Management LLC
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of September 30, 2024)
|
Sector Allocation
(As of September 30, 2024)
|
Geographic Allocation
(As of September 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Twist Bioscience Corp | US Equity | Healthcare | United States | 8.10% |
| CareDx Inc | US Equity | Healthcare | United States | 7.07% |
| Recursion Pharmaceuticals Inc Cl A | US Equity | Healthcare | United States | 6.07% |
| CRISPR Therapeutics AG | International Equity | Healthcare | Other European | 5.92% |
| Intellia Therapeutics Inc | US Equity | Healthcare | United States | 4.56% |
| Adaptive Biotechnologies Corp | US Equity | Healthcare | United States | 4.24% |
| Veracyte Inc | US Equity | Healthcare | United States | 4.18% |
| 10X Genomics Inc | US Equity | Healthcare | United States | 4.11% |
| Ionis Pharmaceuticals Inc | US Equity | Healthcare | United States | 3.96% |
| Nurix Therapeutics Inc | US Equity | Healthcare | United States | 3.54% |
Performance Data
(As of September 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.47
|
7.82
|
-10.56
|
-19.78
|
-8.06
|
-
|
-
|
-
|
|
Benchmark
|
3.15
|
10.54
|
9.96
|
17.24
|
26.74
|
9.52
|
10.95
|
8.09
|
|
Quartile Ranking
|
4
|
1
|
4
|
4
|
4
|
-
|
-
|
-
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
13.12
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|